Comparative effects of calcitonin and clodronate in hypercalcaemia. 1987

S Ljunghall, and J Rastad, and G Akerström
Department of Internal Medicine, University Hospital, Uppsala, Sweden.

Both calcitonin and clodronate inhibit bone resorption and have therefore been used as therapy for malignancy-associated hypercalcaemia. In order to evaluate their effects a compilation was made of data from 78 patients receiving oral or intravenous clodronate which was compared with a previous review of the effects of calcitonin. Both drugs induced significant reductions of serum calcium but the decrease was greater with clodronate, particularly when given intravenously. Whereas the response to calcitonin generally was of short duration, clodronate was capable of maintaining normal serum calcium values over several weeks with oral administration. Thus, from the clinical point of view clodronate is a very useful adjunct to the available therapy, but the limited experience so far has not fully outlined its position in the management of patients with hypercalcaemia.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002116 Calcitonin A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults. Thyrocalcitonin,Calcitonin(1-32),Calcitrin,Ciba 47175-BA,Eel Calcitonin,Calcitonin, Eel,Ciba 47175 BA,Ciba 47175BA
D004002 Clodronic Acid A diphosphonate which affects calcium metabolism. It inhibits bone resorption and soft tissue calcification. Clodronate,Dichloromethylene Diphosphonate,Bonefos,Cl2MDP,Clodronate Disodium,Clodronate Sodium,Dichloromethane Diphosphonate,Dichloromethanediphosphonate,Dichloromethanediphosphonic Acid,Dichloromethylene Biphosphonate,Dichloromethylenebisphosphonate,Acid, Clodronic,Acid, Dichloromethanediphosphonic,Biphosphonate, Dichloromethylene,Diphosphonate, Dichloromethane,Diphosphonate, Dichloromethylene,Disodium, Clodronate,Sodium, Clodronate
D004164 Diphosphonates Organic compounds which contain P-C-P bonds, where P stands for phosphonates or phosphonic acids. These compounds affect calcium metabolism. They inhibit ectopic calcification and slow down bone resorption and bone turnover. Technetium complexes of diphosphonates have been used successfully as bone scanning agents. Bisphosphonate,Bisphosphonates
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006934 Hypercalcemia Abnormally high level of calcium in the blood. Milk-Alkali Syndrome,Hypercalcemias,Milk Alkali Syndrome,Syndrome, Milk-Alkali
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

S Ljunghall, and J Rastad, and G Akerström
January 1993, European journal of cancer (Oxford, England : 1990),
S Ljunghall, and J Rastad, and G Akerström
July 1968, Lancet (London, England),
S Ljunghall, and J Rastad, and G Akerström
July 1968, Lancet (London, England),
S Ljunghall, and J Rastad, and G Akerström
May 1985, British journal of cancer,
S Ljunghall, and J Rastad, and G Akerström
October 1984, British medical journal (Clinical research ed.),
S Ljunghall, and J Rastad, and G Akerström
December 1990, Lancet (London, England),
S Ljunghall, and J Rastad, and G Akerström
January 1991, Bone,
S Ljunghall, and J Rastad, and G Akerström
January 1978, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
S Ljunghall, and J Rastad, and G Akerström
April 1971, Lancet (London, England),
Copied contents to your clipboard!